Psychiatry Investig.  2024 Jan;21(1):28-36. 10.30773/pi.2023.0049.

Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study

• Han S
• Kim SY
• Jung YE
• Kim W
• Seo JS
• Sohn I
• Lee K
• Lee JH
• Chung SK
• Lee SY
• Hong JW
• Yoon BH
• Woo YS
• Han C
• Chang JG
• Bahk WM
• Song HR
• Hong M

• KMID: 2551065
• DOI: http://doi.org/10.30773/pi.2023.0049

Abstract

Objective
We aimed to identify the expectations and preferences for medication and medical decision-making in patients with major psychiatric disorders.
Methods
A survey was conducted among patients with major psychiatric disorders who visited psychiatric outpatient clinics at 15 hospitals between 2016 and 2018 in Korea. The survey consisted of 12 questions about demographic variables and opinions on their expectations for medication, important medical decision-makers, and preferred drug type. The most preferred value in each category in the total population was identified, and differences in the preference ratio of each item among the disease groups were compared.
Results
A total of 707 participants were surveyed. In the total population, patients reported high efficacy (44.01%±21.44%) as the main wish for medication, themselves (37.39%±22.57%) and a doctor (35.27%±22.88%) as the main decision makers, and tablet/capsule (36.16%±30.69%) as the preferred type of drug. In the depressive disorders group, the preference ratio of high efficacy was significantly lower, and the preference ratio of a small amount was significantly higher than that of the psychotic disorder and bipolar disorder groups. The preference ratio of a doctor as an important decision maker in the bipolar disorder group was higher compared to the other groups.
Conclusion
This study revealed the preference for medications and showed differences among patients with psychiatric disorders. Providing personalized medicine that considers a patient’s preference for the drug may contribute to the improvement of drug compliance and outcomes.

Keyword

Decision making; Patient preference; Mental illness; Pharmacotherapy